MedPlus and SureScripts Enter into an Agreement

Published Online: Thursday, April 1, 2004

MedPlus, a subsidiary of Quest Diagnostics Inc, has partnered with SureScripts to provide physicians with electronic prescribing capabilities. Quest Diagnostics is the nation's leading provider of diagnostic testing, information, and services. MedPlus is Quest Diagnostics' health care information technology subsidiary. Sure- Scripts is the pioneer in a growing movement to harness technology to enhance the safety and quality of prescribing with its SureScripts Messenger Services network.

Under the agreement, eMaxx?Quest Diagnostics' physician portal solution?will hook up to SureScripts' network, allowing physicians to send prescription orders and respond to prescription- renewal requests electronically, reducing the time spent telephoning and faxing. Physicians using eMaxx can order diagnostic tests and review laboratory test results on-line, view clinical and administrative information from a range of sources, and prescribe medication at the point of care.

Latest Articles
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.
Chronic kidney disease incidence has grown faster than many of its common comorbidities such as diabetes and hypertension, and medications may be an underappreciated driver of this growth.
President Barack Obama’s fiscal year 2017 budget proposal calls for an additional $1.1 billion to combat the nation’s spiraling opioid epidemic.
Baxter International is voluntarily recalling intravenous solution due to leaking containers and the potential for particulate matter.
Latest Issues